Optibiotix increases investment

York-based OptiBiotix Health, a life sciences business which is developing compounds to tackle obesity, high cholesterol, diabetes and skin care, has upped its investment in a majority owned subsidiary. OptiBiotix has made a further investment in The Healthy Weight Loss Company (THWLC) to provide working capital to support marketing and an increase in stock levels. The business said this investment increases OptiBiotix’s shareholding in THWLC to 64 per cent.

Stephen O’Hara, chief executive of OptiBiotix, said: “We are really pleased with the progress of THWLC and the rapid sales growth of its GoFigure products which have shown the unique ability of our SlimBiome technology to help customers lose weight without feeling hungry, leading to easier and more successful dieting. Our belief in the potential of THWLC is demonstrated by this additional investment which provides funds to invest in marketing, to build stock levels to meet the seasonal demand for weight management products, and to support an increase in retail listings, particularly with major retail outlets.”

See the article in full at InsiderMedia.com

Important information

This information is of a general nature and does not constitute an offer to provide services.

The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice.

The value of investments and/or any income arising from them may fluctuate.

Past performance is not necessarily a guide to future performance.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.